4-(benzyloxy)-5-methoxy-2-nitrobenzaldehyde, 95.0%, 500mg

(3-Chloro-4-cyanophenyl)boronic acid, 95.0%, 25g

6-Chloro-2,3-dihydrobenzofuran, 95+%, 1g

3-(4-methylpiperazinomethyl)benzophenone, 97.0%, 1g

1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-, 98%, 100mg

3-Chlorohexane, 97%, 1g

2,6-Difluoro-3-hydroxybenzamide, 95%, 250mg

1,2,3,4,5,6-Hexahydro-[2,4']bipyridinyl, 95.0%, 1g

GC capillary column ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-Bromo-5-chlorobenzenesulfonyl chloride, 97.0%, 1g

1,4-DIOXASPIRO[4.4]NONAN-7-OL, 95.0%, 500mg

4-Chloro-5,6-dimethyl-pyrimidin-2-ylamine, 1g

6-Bromoimidazo[1,2-a]pyridin-2-amine hydrochloride, 95%, 1g